DatasetName,ARRB1_M(410) ARRB1_S(400) ARRB1_S(404) ARRB1_S(412) ARRB1_T(410),ARRB1_M(412) ARRB1_S(15) ARRB1_S(403) ARRB1_T(402)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,0.6074661788327969,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.635357182999016,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.6011434798597934,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.6106818907117961,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.6173119638404339,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,0.5989178034534024,
GF2025_P2_Sph,0.6181095562791677,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.6502792316185368,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,0.6116355959749968,
RB2022_5_PreEndurance,0.6374441235905068,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.6448520216718836,
WZ2023_Pu_010_30min,0.637756549125732,0.42660807404532597
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,0.6371248731496084,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.6218687205953484,
RB2022_8_RecoveryEndurance,0.6399586982688902,
KBE2022_Log2_Ex_14_U,0.6487496894349071,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.6179210806311677,
JJ2018_Ratio H/L normalized___1,0.6095822715428523,
ZQ2022_C2,,
RB2022_5_PreSprint,0.6517540110089411,
PG2020_Intensity 8h_C,0.5802339219262488,
AH2018_SILAC_MR_2_N,0.6297301578547729,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,0.5722371445080507,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5258788402791039,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,0.6104944640448811,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.5545757164116859,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,0.639312472867795,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,0.6327828265267,
GF2025_P6_Sph,0.5992067958820664,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.6197460365928323,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.6416525923646439,0.4376912443305927
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.6534308960623004,
WZ2023_Pu_005_10min,0.6062917005440174,0.44606308605409345
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.6023174533370712,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.6227950431559206,0.4315843224188963
AH2018_SILAC_MR_2_X,0.6173125547477805,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.59420906451801,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,0.6245076242563261,
EJN2021_3_Rest_Basal,0.614750923249861,0.380789453313291
CR2017_Ratio Replicate 1.3,0.5949055465039803,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.623456048675388,
JJ2018_Ratio M/L normalized pP3,0.6113247606133949,
AH2018_SILAC_M_2_N,0.6234452713509936,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,0.6155849817794014,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.6301640863101664,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.6299993333098766,0.4389889173502979
CK2022_11 40-1,0.5989248634192007,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.6231155878455997,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.6368950612840644,0.42014378326733604
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5914013617894206,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.6194746573318455,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,0.6302572189705398,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.5421867657077637,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.6080969569953014,
CK2022_1 200-1,0.6210101809688775,
PG2020_Intensity Mock_10h_D,0.6011410099417488,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.6055345918643259,
RCJD2014_5min_1,0.6425188217888186,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.605402326592253,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.6225612891422098,
KBE2022_Log2_Ex_8_T,0.6441968486724091,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.6135466461070326,
CK2022_3 40-1,0.5753810539192441,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.6136245716925964,
HH2022_Reporter intensity 8,0.6192772683793131,0.44097394565981585
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5922422731557928,
EJN2021_5_Rest_Basal,0.6069378975324399,0.38634080283995237
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.6230150286605461,
YA2020_Reporter_intensity_Normal_No.1,0.6194422479686105,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,0.619402604335422,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.572791640106099,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,0.6328488650700704,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.6120661107156236,
HS2024_8_I_T3,,
CF2017_EOC 3,0.6160574863387509,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.6293027488651559,0.4419227022613212
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5801298809186856,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.601282091323932,
KS2014_Intensity N3,,
RB2022_4_RecoveryEndurance,0.6496579737632884,
RB2022_5_RecoveryEndurance,0.6434787560114591,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.6119622728000189,
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,0.5969820317988345,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5686648032491961,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,0.5841992827899644,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.6234445407480107,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.6479313686848677,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.6258064037439917,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,0.6047371104773384,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.644471469526039,
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.6619725858729876,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.4112517118756579
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.6358434145210557,
AH2018_SILAC_IT_3_X,0.6259861708804848,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,0.43237845360853033
SR2019_HCC1954_Biol_repl_2,0.6044449319622561,
CK2022_14 40-1,0.5470730417160733,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.6018108825957003,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.6174967784402234,
DL2023_control-1,,
AR2021_ALG 10 μM,,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.6270679192481385,
EJN2021_4_Rest_Ins,0.609605645630856,0.4572334805171694
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5595054004789175,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.6142835873319952,
EJN2021_1_Rest_Ins,0.6201947214284227,0.45198043654208936
HH2022_Reporter intensity 3,,0.42452508174303993
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.6130751883715776,
JW2021_After_3,,
GF2025_P8_Sph,0.5987707481229817,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.6227293208036146,
CK2022_11 200-1,0.6496514432976388,
CK2022_12 200-1,0.6297353391651166,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,0.42947297862140765
WZ2023_Su_010_20min,0.6311109789515739,0.4200376968690805
AH2018_TMTMS2_2_N,0.6191061208566758,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.6366599929482522,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.44120062959748774
AH2018_TMTMS3_Pool,0.5868024213458337,
KS2014_Intensity N4,,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5712809006186221,
CK2022_14 200-1,0.6063062400797065,
SR2019_Hs578T_Biol_repl_1,0.5928864432878156,
RB2022_7_PostSprint,0.615285684507126,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5809508644470567,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5915141317837135,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.6151968948770744,0.45488551967476437
SR2019_LM2_Biol_repl_4,0.5799365386365416,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5899804016437831,
GF2025_P1_Adh,0.5822884753044703,
GF2025_P1_Sph,0.6138359735339043,
EJN2021_5_Ex_Basal,0.6058534611469053,0.4585301040353019
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.6020204879731087,0.4490534013588887
CF2017_EOC 1,0.5824870412509471,
CK2022_3 200-1,0.6221517339709645,
AH2018_LFQ_IT_3_C,0.6227584705664186,
SR2019_Hs578T_Biol_repl_2,0.5944277869466512,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,0.5948072755479318,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.6108654339696113,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,0.5933885072369037,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.5765130743494823,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.6204590244315232,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.6013399669399291,
AR2021_ALG 1 μM,,
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.6162945519454305,0.4665166657628132
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.5897681105078381,
CR2017_Ratio Replicate 3.2,0.5910517512220073,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5679977812736443,
CK2022_9 16-1,0.6232198740620614,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.6049200422891048,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5974073780576171,
CK2022_16 16-1,0.5797512730858856,
FS2019_db/db3,,
CK2022_15 40-1,0.5446955635630565,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.6022268945268283,0.41959132925115117
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.654789236189289,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.6231515696629817,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.5880962498848153,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.6489054753431374,
AH2018_LFQ_M_1_N,0.6278079748720591,
KBE2022_Log2_Ex_27_U,0.6614267594571885,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.6120350316022927,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.6224402758146289,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.6312911866455371,
YA2020_Reporter_intensity_Normal_No.4,0.6055574510112998,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5755510610947668,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.6069724335451101,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.6519904573695792,
SR2019_SKBR3_Biol_repl_3,0.6234516588442391,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.6069700259473653,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.6711934274762946,
HH2022_Reporter intensity 6,0.6184155900491405,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.6048828320904633,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.6202667694751128,
GF2025_P3_Adh,0.6057760433876398,
SR2019_JIMT1_Biol_repl_2,0.5843844434719658,
AH2018_TMTMS2_1_C,0.6230545817337714,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.6065527983649442,
KBE2022_Log2_Ex_19_U,0.6342161388496109,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,0.599676949652129,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.6151285979875573,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.5747055662839882,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.6435275977864954,
RB2022_7_RecoverySprint,0.6099739158357098,
YA2020_Reporter_intensity_Normal_No.3,0.5916286497459152,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.6180037525673038,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.6053538665825655,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,
HH2022_Reporter intensity 1,,0.4269387642299031
HH2022_Reporter intensity 2,0.5969789553482668,0.42208121930144626
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.6118235313995364,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,0.6037907127053342,
EP2017_Untreated R#2 log2 ratio,0.5629950164586612,
SR2019_LM2_Biol_repl_3,0.5849838157162737,
RB2022_4_RecoveryStrength,0.6097479236337029,
CR2017_Ratio Replicate 2,0.599804431417984,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.5815369825107028,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.6466006818133456,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.5851332037032432,
KBE2022_Log2_Ex_9_U,0.6211141142724953,
AH2018_SILAC_M_3_N,0.6230447050528328,
KBE2022_Log2_Ex_13_T,0.6321286187502726,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,0.629470256241507,
PG2020_Intensity Mock_10h_C,0.601072896800437,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.6231705174003525,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.5751460020200743,
RB2022_7_RecoveryEndurance,0.6488255997806014,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.6138600469545065,0.44709181161893935
TM2022_S2.12h.B,,
RN2012_L15,0.6392277482447957,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5821011383143764,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.6332637509301775,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.6109838085886431,
CK2022_5 200-1,0.6128346084649358,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,0.620796549457268,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.6317567282043622,
AH2018_SILAC_3_C,0.6232227488222473,
EJN2021_5_Rest_Ins,0.6068997660355341,0.45081690332588864
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,0.5812007017597878,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,0.6070527979198493,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,0.5933158220662237,
EJN2021_2_Ex_Ins,0.6122271450799187,0.42672065813551163
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.6247436756327781,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,0.6158157257337454,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.6354533119502452,
AH2018_SILAC_IT_2_N,0.6275873270258335,
AH2018_SILAC_IT_1_X,0.6262227112375482,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,0.6124524257826026,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5939887346492215,
WZ2023_Pe_025_20min,0.6047881838023509,0.4323761546194973
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.6162643692187286,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.621119945054906,
RN2012_H06,0.6285576822356189,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.6292951624696299,0.423770970153184
SR2019_HCC1419_Biol_repl_4,0.5925709060203376,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,0.5891267027742113,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.6123694295763868,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5808879202484512,
WZ2023_Su_025_10min,0.6155895489352584,0.43283521547763437
AH2018_LFQ_IT_4_X,0.623475174027107,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,0.6261148730940924,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.640733464944949,0.410199277455005
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.5971188276508606,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5813572604984409,
LY2019_P7+,0.5672999114579612,
EP2017_Untreated R#1 normalized log2 ratio,0.5551295949260906,
RN2012_L10,,
PG2020_Intensity 4h_C,0.5908524180665371,
EP2017_Mitotic R#3 normalized log2 ratio,0.5728309535563446,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.6484426808700686,
RB2022_8_PostStrength,0.6504772758144977,
AH2018_SILAC_IT_2_X,0.6264692158842664,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.6658142403103221,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5827507346220948,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5989257236512955,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5993588130770624,
GF2025_P9_Sph,0.5963042089788914,
CK2022_6 200-1,0.6116989501120932,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.584671017097454,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,0.6014778414281994,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,0.5980923490167577,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.5850750084557981,
EP2017_Untreated R#3 normalized log2 ratio,0.5873341167891848,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.6119589126895175,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.6055861611360955,
RB2022_7_PostEndurance,0.604015031824529,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5742387124521049,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.6228536767001194,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.6475662135429896,
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.6172687582351248,0.4676843516801178
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.6232470536093087,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,
PG2020_Intensity CT_C,0.5611857995876491,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.6368594718540611,
EP2017_Untreated R#3 log2 ratio,0.587030571446087,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5946605286801152,
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.6406365933437673,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,0.6444684261942492,
CR2017_Ratio Replicate 2.3,0.5828772110506039,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5781856732592445,
YA2020_Reporter_intensity_Normal_No.2,0.6183314264097136,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.6202761200741238,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.6418476554875021,
CK2022_2 16-1,0.6065848360305346,
RAM2015_Log2 B,0.597280083446997,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.611916845447402,0.3951388685421342
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.5800668388309169,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,0.6094054266588576,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.5976435632593343,
WZ2023_Su_025_30min,0.6312034161526932,0.4322772492840536
AH2018_LFQ_4_N,0.6197971663947012,
CR2017_Ratio Replicate 1.2,0.5919039441397411,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.619563168011623,0.4332163897814747
AH2018_SILAC_M_1_X,0.6138738300674835,
RB2022_7_PreEndurance,0.6446697017240688,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5628206832103844,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.566303514075243,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5877625354057973,
SR2019_Hs578T_Biol_repl_4,0.5960305491163259,
RB2022_8_PreStrength,0.6285652411430896,
KS2014_Intensity C5,,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,0.6439856293066575,
RNJ2017_Log2_ratio_Tstim:Trest_D2,0.5911517250457151,
GF2025_P9_Adh,0.5808595455623389,
RB2022_3_PostStrength,0.6362486920299637,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.6233934398517709,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5805162221675179,
AH2018_LFQ_2_X,0.6058461452530874,
PG2020_Intensity 2h_B,0.5528767345520743,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,0.6470629999790681,
KS2014_Intensity E15_3,,
GF2025_P3_Sph,0.6438983533176612,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.6106035558158334,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.42502682603297937
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.627307625753459,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,0.6546113464393682,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.59127662028906,
ZQ2022_N1,,
LY2019_P6-,0.6112757518390184,
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.6128509172508283,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.6254297677487912,
AH2018_LFQ_3_N,0.6105083437028274,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,0.6119572148055468,
KBE2022_Log2_Ex_13_U,0.6472667591066558,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,0.5762069859965853,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.6030586147076546,
CK2022_7 40-1,0.5698037249830697,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.571368891781459,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.6094448765545978,
RB2022_5_PostEndurance,0.5970043706748271,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.5940199842339792,0.42551891568439604
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.6219846357967371,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.5428788171739166,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,0.647219353672708,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,0.6077658186783438,0.36910880843950833
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.6161990125591366,0.3586512013464381
EP2017_Pervanadate R#3 log2 ratio,0.5630090861437593,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.5752158741821235,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.6266633633515255,
AH2018_LFQ_M_4_C,0.6217348980805292,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,0.5762092830547265,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.6516335404821664,
LY2019_P3-,0.6648032024308894,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.6066444567103264,0.45720792438842883
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.6253913578155217,0.4354900961795585
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.6089458365913784,0.45438879827678025
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.5662558879691477,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.6354240620583524,0.4279152033083771
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5916557792108217,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,0.5980981294384543,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.6177217426578319,
RB2022_4_PreSprint,0.6652055024687564,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5883370200180014,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,0.636962028276787,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.6120841409883232,
LY2019_P8+,0.6239564841405822,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,0.5927728620737689,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.40267031161008504
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.6298929826385398,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.6365104926152905,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5878663489688071,
LY2019_P2-,0.5529586873529785,
AH2018_LFQ_IT_1_X,0.6138734990106657,
JJ2018_Ratio H/L normalized pP3___1,0.6029980821713731,
RB2022_8_RecoveryStrength,0.5900732200611751,
WZ2023_Pe_005_20min,0.5940256786634078,0.4270424855907871
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.6169512076271589,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5719604240684703,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.5547943247261438,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.6561072085416989,
AH2018_TMTMS3_3_N,0.5906985641833782,
SR2019_HCC1419_Biol_repl_2,0.5914532916996428,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.6191252936162633,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5666376816116917,
KBE2022_Log2_Ex_36_T,0.6587866300772436,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.6295818795522989,0.41867772489218325
KS2014_Intensity C2,,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.6384178603375784,
CK2022_9 200-1,0.6503490997307795,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.6519628186664346,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.5922422509861051,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5944226038271829,
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,0.6123212935104345,0.4623817993239136
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.6341538410578137,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5550163618104691,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.6110143921336038,0.4250585324960737
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,0.6214466981603696,
HS2024_5_I_T3,,
KS2014_Intensity N1,,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.6006326685112627,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.5802310281333515,
AH2018_SILAC_MR_2_C,0.6205395636623632,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.5282016683064009,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.6139161069153698,
JJ2018_Ratio H/M normalized___1,0.576223345852427,
RCJD2014_15min_2,0.6059660040187688,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.5672696848309856,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,0.6388412619872625,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,0.5827466923516565,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,0.5961399711867208,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.6002181278039208,0.42799749452029523
KBE2022_Log2_Ex_29_U,0.6431742148976012,
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.6107570473706831,
AH2018_LFQ_IT_4_N,0.6230298553197594,
CK2022_15 200-1,0.6034797551292614,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.5764689227156851,
JJ2018_Ratio M/L normalized pP3___1,0.6105107897315087,
KBE2022_Log2_Ex_34_T,0.6684518587687845,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5649817323238565,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.6218451693878084,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.6252774057175036,0.42036614971290853
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.6137305729397461,0.37243081567037334
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5875417918331702,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.6194574889616202,
KBE2022_Log2_Ex_44_U,0.6415518650001534,
WZ2023_Pe_010_20min,0.5992303374802738,0.4316856540810273
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5657028013996023,
RB2022_3_PreStrength,0.6441509352180237,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.5501746387110377,
KS2014_Intensity C1,,
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,0.6231120720360758,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.6234452713509936,
AH2018_SILAC_M_2_X,0.6224312283676217,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.6370486854358131,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.624446153831249,0.41652972272916794
PG2020_Intensity 6h_C,0.583544450508617,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.6148903045775899,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.6210015322354887,
CK2022_15 16-1,0.5881503896044092,
CK2022_3 16-1,0.6053467480938934,
LY2019_P4-,0.620730646485348,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5768051977547062,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.6056910113924607,
CK2022_10 16-1,0.6237246592957055,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.4662006231090067
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,0.6132904251391841,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5927598417341782,
EJN2021_2_Ex_Basal,0.6162541965138487,0.46490671057099336
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,
AR2021_L41 10 μM,,
CF2017_EOC 2,0.6148471144092033,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.6119003864012971,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,0.6102740181243935,
RB2022_7_PreSprint,0.6399910822991552,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,0.601243718178299,
ZX2022_CB treated Replicate 1,0.6221740086797061,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5910192982408995,0.42457333061472885
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.6178303434540928,
AR2021_L41 1 μM,,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.6219580010572588,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.6186221308147329,
KS2014_Intensity C4,,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.6207690167360541,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.6416299693253057,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.6213179579312597,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.6026525328092374,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.6313535466204414,
AH2018_SILAC_IT_3_C,0.6129293433188632,
WZ2023_Pu_025_10min,0.6056975319191247,0.4441366997319347
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.5790768507175368,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,0.5926436456111401,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.5967006293707282,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5985694459708789,0.42672844889310296
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.6226708327043354,
KS2014_Intensity C6,,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5755061250097289,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.615813099612015,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.5338741352721078,
AH2018_SILAC_IT_2_C,0.614940415401878,
CK2022_5 40-1,0.571692448482672,
AH2018_LFQ_3_X,0.6141288681958563,
UK2020_UA_3,0.6100025761407635,
LY2019_P7-,0.5986458992304612,
GF2025_P5_Adh,0.5697430982628965,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,0.6023343507305571,
CR2017_Ratio Replicate 2.2,0.6045955645498753,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.6217504863611525,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.5883719084817772,
PG2020_Intensity CT_B,0.5505175935460211,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.622065444248846,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5741017245043787,
AH2018_LFQ_3_C,0.6171343952290818,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.6182480600286194,
YA2020_Reporter_intensity_Cancer_No.4,0.6043853631977638,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.6194762246417188,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.6474970869348076,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.6159549805169022,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5911165596411883,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.637113543344719,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5989794539614653,
AH2018_TMTMS2_1_X,0.6230928704000542,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.6063501494622242,0.402595294896458
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.5790340709895991,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5823711051590617,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.6137762515260493,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.5878961762090515,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5946765265526204,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.6539086091626606,
EP2017_Untreated R#2 normalized log2 ratio,0.5631055422770395,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5709626757641157,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5874778433255651,
AS2011_Ratio H/L Normalized RNAi_2_1,,
